Skip to content

Effect of combined of supplement with carnitine and coenzyme Q10, versus therapeutic lifestyle changes (TLC Diet) diet on myocardial infarction patients.

Evaluation of effects of combined of supplement with carnitine and coenzyme Q10, versus therapeutic lifestyle changes (TLC Diet) diet on cardiovascular risk factors, function and quality of life after angioplasty in patients with experience of myocardial infarction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2282620150719N1
Enrollment
128
Registered
2015-07-19
Start date
2015-05-09
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myocardial infarction. Acute myocardial infarction

Interventions

Intervention 1: control group: without any intervention, patient receive routine care. Intervention 2: Diet and supplement group: patient receive therapeutic life style change diet and two supplement
Treatment - Other
Lifestyle
control group: without any intervention, patient receive routine care
Diet and supplement group: patient receive therapeutic life style change diet and two supplement , l-carnitin with dose 1200 mg , co- Q10 with dose 150 mg
Diet group: patient receive therapeutic life style change diet suitable with weight and individual properties
supplement group: patient receive two supplement , l-carnitin with dose 1200 mg , co- Q10 with dose 150 mg

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: first experience of myocardial infarction; age between 40 -65; candidate for angioplasty revascularization; LDL >130? without anti lowering lipid six month ago; ejection fraction between 30-60; receive atorvastatin 80 mg daily; exclusion criteria: allergy with atorvastatin; history of cardiac event after angioplasty; patient with arrhythmia or congestive heart failure; history of consumption of antioxidant such as vitamin C, E and omega 3; history of consumption warfarin; history of documented psychological disease ; leave the patient before 60 days after intervention in RCT;

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
LDL. Timepoint: 24 hours after myocardial infarction than 3 month after intervention. Method of measurement: enzymatic method calculate.

Secondary

MeasureTime frame
Quality of life. Timepoint: 10 days after myocardiad in farction. Method of measurement: MacNew questionaire.;Ejection fraction. Timepoint: 24 houre after myocardiad in farction. Method of measurement: echocardiography by specilalist.;Triglyceride (TG). Timepoint: 24 houre after myocardiad in farction and 3 mouth after intervention. Method of measurement: Photometric method.;High-density lipoprotein (HDL). Timepoint: 24 houre after myocardiad in farction and 3 mouth after intervention. Method of measurement: Photometric method.;Physical Activity. Timepoint: 7 days before myocardial infarction then 3 month after intervention. Method of measurement: Intinternational Physical Activity Questionnaire - Short Form (IPAQ-SF).;H- CRP. Timepoint: 24 houre after myocardiad in farction and 3 mouth after intervention. Method of measurement: ELISA by micropipette reader.;IL-6. Timepoint: 24 houre after myocardiad in farction and 3 mouth after intervention. Method of measurement: ELISA.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hassan Eftekhari

Shiraz University of Medical Sciences

h_eftekhar@yahoo.com+98 71 3725 1001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026